Metiluracil, tablets 500 mg 50 pcs

Methyluracil has anabolic activity.

It has hematopoietic, leukopoietic, immunostimulating, anti-inflammatory effect.

Normalizing the nucleic exchange, accelerates the process of regeneration in wounds by accelerating the growth and granulation maturation of tissue and epithelialization (including in the rapidly proliferating cells of the mucous coat of the gastrointestinal tract), stimulates erythro- and leukopoiesis, cellular and humoral immune factors.

Indications

Agranulocytic tonsillitis;
nutritional-toxic aleukia;
chronic benzene intoxication;
slow healing wounds;
burns;
bone fractures;
peptic ulcer of the stomach and duodenum;
chronic gastritis;
hepatitis;
pancreatitis;
lesions caused by radiation therapy.

Pharmacological effect

Methyluracil has anabolic activity.

It has hematopoietic, leukopoietic, immunostimulating, anti-inflammatory effects.

By normalizing nucleic acid metabolism, it accelerates regeneration processes in wounds, accelerating the growth and granulation maturation of tissue and epithelialization (including in rapidly proliferating cells of the mucous membrane of the gastrointestinal tract), stimulates erythro- and leukopoiesis, cellular and humoral immunity factors.

Special instructions

It is advisable to prescribe methyluracil for mild forms of leukopenia. For moderate disease, the drug is taken only after the restoration of blood cell regeneration disorders. In severe forms of hematopoietic lesions, methyluracil is not prescribed.

Impact on the ability to drive vehicles. Wed and fur.:

There is no information on the effect of the drug on the ability to drive vehicles and operate complex machinery. Until the patient’s individual reaction to the drug is clarified, you should refrain from driving vehicles or operating machinery, given that the following adverse reactions from the nervous system are possible during treatment with methyluracil: dizziness.

Active ingredient

Dioxomethyltetrahydropyrimidine

Composition

One tablet contains:

Active substance:
Dioxomethyltetrahydropyrimidine – 0.5 g
Excipients:
potato starch – 0.130 g
calcium stearate – 0.007 g
povidone-K30 – 0.049 g
talc – 0.014 g

Pregnancy

During pregnancy and lactation, the expected benefit for the mother should be weighed against the potential risk for the fetus and child.

Contraindications

Leukemic forms of leukemia (especially myeloid), lymphogranulomatosis, malignant diseases of the bone marrow.

Side Effects

Rarely – allergic skin reactions (urticarial rash), headache, dizziness.

Interaction

Strengthens the anti-radiation effect of cystamine.

Overdose

In clinical use, no cases of overdose have been recorded so far.

Storage conditions

At a temperature not exceeding 25 °C.

Shelf life

2 years

Manufacturer

Update of PFC JSC, Russia